申请人:Bayer Pharma Aktiengesellschaft
公开号:US11230540B2
公开(公告)日:2022-01-25
The present invention relates to novel substituted 1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.
本发明涉及新型取代的 1,2,4-三唑衍生物、制备此类化合物的工艺、含有此类化合物的药物组合物,以及使用此类化合物或组合物治疗和/或预防疾病,特别是治疗和/或预防肾病和心血管疾病。